What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)

The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women

(2020) Victoria G. Woof et al.   BMC CANCER

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

(2020) Nora Pashayan et al.   Nature Reviews Clinical Oncology

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

(2019) D. Gareth R. Evans et al.   BREAST CANCER RESEARCH AND TREATMENT

How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies

(2019) Hannah Long et al.   BRITISH JOURNAL OF CANCER

Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials

(2019) Michelle Harvie et al.   BMC CANCER

Engagement barriers and service inequities in the NHS Breast Screening Programme: Views from British-Pakistani women

(2019) Victoria G Woof et al.   JOURNAL OF MEDICAL SCREENING

Psychosocial issues of a population approach to high genetic risk identification: Behavioural, emotional and informed choice issues

(2018) David P. French et al.   BREAST

Psychological impact of providing women with personalised 10-year breast cancer risk estimates

(2018) David P. French et al.   BRITISH JOURNAL OF CANCER

Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses: A Case Study Of A Stratified Breast Screening Programme

(2017) A Donten et al.   VALUE IN HEALTH

Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis

(2017) Ewan Gray et al.   VALUE IN HEALTH

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer

(2017) Natalie J. Engmann et al.   JAMA Oncology

Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer

(2016) Rulla M. Tamimi et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Breast cancer risk feedback to women in the UK NHS breast screening population

(2016) D Gareth R Evans et al.   BRITISH JOURNAL OF CANCER

Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations

(2016) Cynthia P. Iglesias et al.   PHARMACOECONOMICS

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis

(2016) Gareth J Hollands et al.   BMJ-British Medical Journal

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis

(2016) Gareth J Hollands et al.   BMJ-British Medical Journal

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States

(2016) Paige Maas et al.   JAMA Oncology

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial

(2015) Jolyn Hersch et al.   LANCET

Process evaluation of complex interventions: Medical Research Council guidance

(2015) G. F. Moore et al.   BMJ-British Medical Journal

Process evaluation of complex interventions: Medical Research Council guidance

(2015) G. F. Moore et al.   BMJ-British Medical Journal

Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic

(2014) L S Donnelly et al.   BRITISH JOURNAL OF CANCER

Enthusiasm for cancer screening in Great Britain: a general population survey

(2014) J Waller et al.   BRITISH JOURNAL OF CANCER

Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention

(2014) D. G. Evans et al.   Cancer Prevention Research

Systematic review of the psychological consequences of false-positive screening mammograms

(2014) M Bond et al.   HEALTH TECHNOLOGY ASSESSMENT

Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study

(2014) Ruth H Jack et al.   BMJ Open

Scoring the Icecap-a Capability Instrument. Estimation of a UK General Population Tariff

(2013) Terry N. Flynn et al.   HEALTH ECONOMICS

Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study: Table 1

(2013) Jo Waller et al.   BMJ Open

Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention

(2012) D. G. R. Evans et al.   Cancer Prevention Research

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

(2012) Ben van Hout et al.   VALUE IN HEALTH

16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010

(2011) D M Parkin et al.   BRITISH JOURNAL OF CANCER

Development of a self-report measure of capability wellbeing for adults: the ICECAP-A

(2011) Hareth Al-Janabi et al.   QUALITY OF LIFE RESEARCH

Estimating attendance for breast cancer screening in ethnic groups in London

(2010) Christine Renshaw et al.   BMC PUBLIC HEALTH

Microcosting Quantity Data Collection Methods

(2009) Kevin D. Frick   MEDICAL CARE

Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

(2008) D Gareth Evans et al.   BMC CANCER

Developing and evaluating complex interventions: the new Medical Research Council guidance

(2008) Peter Craig et al.   BMJ-British Medical Journal